Top Line Teprotumumab Phase III Trial Results Released

March 1, 2019

Horizon Pharma has just released top line results for the Phase III trial of Teprotumumab, a potential new treatment for thyroid eye disease. Detailed Phase III data will be submitted for publication in a peer-reviewed journal and presented at a medical congress later this year. Click this link to learn more: http://bit.ly/2ECfINj

Raymond Douglas, M.D., Ph.D., the study’s co-principal investigator, director of the orbital and thyroid eye disease program ...

Read More

Santa Monica Event Registration!

April 6, 2019

If you are in the Los Angeles area and would like to learn more about Graves' disease, pease join us for a special "Ask the Experts" session co-hosted by the American Association of Endocrine Surgeons and the Graves' Disease and Thyroid Foundation! 

Date/Time: Saturday, April 6th from 5:00 - 6:30 p.m.
Location: Fairmont Miramar Hotel & Bungalows, 101 Wilshire Blvd, Santa Monica, CA, 90401

Click here for details and registration!

Read More

GDATF Statement on the Passing of President George H.W. Bush

Dec. 3, 2018

​Statement from the Graves' Disease and Thyroid Foundation (GDATF) on the passing of President George H.W. Bush:

We were saddened to learn of the passing of Pres. George H.W. Bush, and extend our condolences to his family and friends.

With his diagnosis of Graves' disease in 1991, Pres. Bush not only raised the profile of Graves' disease in the public consciousness, but was also an example of how patients can persevere and lead ...

Read More

Recent News

• Top Line Teprotumumab Phase III Trial Results Released

  March 1, 2019, 8:22 a.m.

• Registration Open for Los Angeles Patient Event!

  Feb. 22, 2019, 11:08 a.m.

• Los Angeles Patient Education Event!

  Feb. 6, 2019, 10:01 a.m.

• Holiday Schedule 2018-19

  Dec. 23, 2018, 8:56 a.m.

• GDATF 2018 Annual Appeal Letter

  Dec. 20, 2018, 10:21 a.m.